sulfasalazine has been researched along with Hemolysis in 11 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an attempt to estimate the frequency of folate deficiency and haemolysis in a group of 25 outpatients with arthritis treated with sulphasalazine (SASP), haematological measurements, including plasma total homocysteine (tHcy) which is a sensitive marker of folate deficiency, serum folate (S-folate), erythrocyte (RBC) folate, S-cobalamin and routine indices of haemolysis were performed." | 7.69 | Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. ( Ekelund, S; Krogh Jensen, M; Svendsen, L, 1996) |
| "In an attempt to estimate the frequency of folate deficiency and haemolysis in a group of 25 outpatients with arthritis treated with sulphasalazine (SASP), haematological measurements, including plasma total homocysteine (tHcy) which is a sensitive marker of folate deficiency, serum folate (S-folate), erythrocyte (RBC) folate, S-cobalamin and routine indices of haemolysis were performed." | 3.69 | Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. ( Ekelund, S; Krogh Jensen, M; Svendsen, L, 1996) |
| "Hemolytic anemia is a well-recognized complication of sulfasalazine treatment." | 1.26 | Hemolytic anemia in patients receiving sulfasalazine. ( Ali, MA; Castelli, M; Goodacre, RL; Hamilton, JD; Seaton, T; Vanderlinden, B, 1978) |
| "In 36 unselected patients with ulcerative colitis or Crohn's disease taking 4." | 1.26 | Hemolysis during salicylazosulfapyridine therapy. ( van Elferen, LW; van Hees, PA; van Rossum, JM; van Tongeren, JH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Sahm, J | 1 |
| de Groot, K | 1 |
| Schreiber, J | 1 |
| BADE, HJ | 1 |
| Tack, CJ | 2 |
| Lutterman, JA | 1 |
| Wetzels, JF | 1 |
| Krogh Jensen, M | 1 |
| Ekelund, S | 1 |
| Svendsen, L | 1 |
| Baadenhuijsen, H | 1 |
| Seuren-Jacobs, HE | 1 |
| Jansen, AP | 1 |
| Goodacre, RL | 1 |
| Ali, MA | 1 |
| Vanderlinden, B | 1 |
| Hamilton, JD | 1 |
| Castelli, M | 1 |
| Seaton, T | 1 |
| van Hees, PA | 1 |
| van Elferen, LW | 1 |
| van Rossum, JM | 1 |
| van Tongeren, JH | 1 |
| Wijnands, MJ | 1 |
| Nuver-Zwart, IH | 1 |
| van Riel, PL | 1 |
| van 't Hof, MA | 1 |
| Gribnau, FW | 1 |
| van De Putte, LB | 1 |
| Kater, F | 1 |
| Cohen, SM | 1 |
| Rosenthal, DS | 1 |
| Karp, PJ | 1 |
1 trial available for sulfasalazine and Hemolysis
| Article | Year |
|---|---|
Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
Topics: Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Haptoglobins; Hemoglobins; Hemolysis; Hemop | 1991 |
10 other studies available for sulfasalazine and Hemolysis
| Article | Year |
|---|---|
Sulfasalazine-induced mononucleosis-like-illness and haemolysis.
Topics: Adult; Antirheumatic Agents; Drug Hypersensitivity Syndrome; Epstein-Barr Virus Infections; Female; | 2021 |
[HEMOLYTIC ANEMIA WITH THE FORMATION OF HEINZ BODIES AFTER SALAZOSULFAPYRIDINE THERAPY].
Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Heinz Bodies; Hemolysis; Pathology; Sulfanilamide; Sulfanil | 1963 |
[Problems in the interpretation of the percentage of glycosylated hemoglobin in patients with diabetes mellitus].
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anemia, Iron-Deficiency; Chromatography, High Pressure L | 1995 |
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patients.
Topics: Adult; Anti-Inflammatory Agents; Child; Diabetes Mellitus, Type 1; Female; Hemoglobin A; Hemolysis; | 1996 |
Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.
Topics: Adolescent; Adult; Aged; Arthritis; Arthritis, Rheumatoid; Colitis, Ulcerative; Erythrocytes; Female | 1996 |
Continuous-flow determination of serum inorganic phosphate with a single reagent--the vanadomolybdate method re-evaluated.
Topics: Acids; Anticoagulants; Bilirubin; Chlorpromazine; Evaluation Studies as Topic; Hemolysis; Humans; Me | 1977 |
Hemolytic anemia in patients receiving sulfasalazine.
Topics: Anemia, Hemolytic; Colitis, Ulcerative; Crohn Disease; Electrophoresis, Starch Gel; Heinz Bodies; He | 1978 |
Hemolysis during salicylazosulfapyridine therapy.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic; Colitis, Ulcerative; Crohn Disease; Female; Hemolysis; H | 1978 |
[Hemolysis, formation of Heinz bodies and of methemoglobin under therapy with Azulfidine (author's transl)].
Topics: Adult; Colitis, Ulcerative; Cyanosis; Diarrhea; Erythrocytes; Female; Headache; Heinz Bodies; Hemato | 1974 |
Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
Topics: Adult; Anemia, Hemolytic; Colitis, Ulcerative; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; | 1968 |